Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Qiuxiao Shi"'
Autor:
Zhao Li, Tianshan She, Hao Yang, Tao Su, Qiuxiao Shi, Ze Tao, Yanru Feng, Fen Yang, Jingqiu Cheng, Xiaofeng Lu
Publikováno v:
Drug Delivery, Vol 29, Iss 1, Pp 1698-1711 (2022)
Multidrug resistance (MDR), which is common in colorectal cancer (CRC), induces high mortality in patients. Due to its robust and selective apoptosis induction in some CRC cells with MDR, tumor necrosis factor-related apoptosis-inducing ligand (TRAIL
Externí odkaz:
https://doaj.org/article/913375aacb15471187edafb8ccd1c214
Publikováno v:
Drug Delivery, Vol 24, Iss 1, Pp 1818-1830 (2017)
Vascular-targeted photodynamic therapy (PDT) is an important strategy for cancer therapy. Conventional vascular-targeted PDT has been achieved by passive photosensitizer (PS) delivery, which involves a high risk of adverse effects. Active PS delivery
Externí odkaz:
https://doaj.org/article/e554ddb99aff4a93ba64c7163279f10e
Autor:
Huawei Cai, Zhao Li, Qiuxiao Shi, Hao Yang, Liu Xiao, Mufeng Li, Hua Lin, Xiaoai Wu, Tianshan She, Lihong Chen, Lin Li, Xiaofeng Lu
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging.
Abstract Purpose Hepatocellular carcinoma (HCC) is a highly vascularized solid carcinoma and tumor vessel–targeted molecular imaging might be effective for early diagnosis of HCC. Herein, we developed a novel trimeric affibody (ZTRI) with highly sp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::472082e9fa1a59911da686d360140db1
https://doi.org/10.1007/s00259-023-06260-x
https://doi.org/10.1007/s00259-023-06260-x
Autor:
Xiaofeng Lu, Qiuxiao Shi, Youmei Jin, Zhao Li, Jingqiu Cheng, Yanru Feng, Hao Yang, Tianshan She, Heng Li, Jie Chen, Ze Tao, Jie Fan
Publikováno v:
Journal of Controlled Release. 340:243-258
Immunotherapies based on immune checkpoint-blocking antibodies have been considered the most attractive cancer treatments in recent years. However, the systemic administration of immune checkpoint-blocking antibodies is limited by low response rates
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::257bc3da2f74d007e1e289278ab62b85
https://doi.org/10.1016/j.jconrel.2021.11.003
https://doi.org/10.1016/j.jconrel.2021.11.003
Autor:
Hao Yang, Xiaofeng Lu, Ze Tao, Jie Fan, Zhao Li, Shengfu Li, Youmei Jin, Qiuxiao Shi, Yanru Feng, Jie Chen, Jingqiu Cheng
Publikováno v:
Applied Microbiology and Biotechnology
Due to their potent immune stimulation, tumor necrosis factor alpha (TNFα) variants with tumor-homing activity are attractive as novel antitumor drugs. The promising antitumor effect of NGR-TNFα in clinical trials triggered extensive interest in de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c7b72217a3d7e1795faa0df7fd2629c
https://doi.org/10.1007/s00253-021-11136-x
https://doi.org/10.1007/s00253-021-11136-x
Autor:
Ze Tao, Tianshan She, Yanru Feng, Shisheng Wang, Heng Li, Xiaofeng Lu, Yan Liang, Zhao Li, Jingqiu Cheng, Hao Yang, Jie Chen, Qiuxiao Shi
Publikováno v:
Theranostics
Chemotherapeutic multidrug resistance (MDR) is the major hindrance for clinical therapy of colorectal cancer (CRC). Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) with selective cytotoxicity might overcome MDR of CRC cells. Unfortuna
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08ead0e1823bcb6e3109d489bdbf9aa7
http://europepmc.org/articles/PMC7977453
http://europepmc.org/articles/PMC7977453
Autor:
Hao Yang, Heng Li, Fen Yang, Ze Tao, Qiuxiao Shi, Tianshan She, Yanru Feng, Zhao Li, Jie Chen, Yi Zhong, Tao Su, Wengjuan Zeng, Yong Zhang, Shisheng Wang, Lan Li, Tingting Long, Dan Long, Jingqiu Cheng, Hong Zhu, Xiaofeng Lu
Publikováno v:
Biomaterials. 295:121994
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5ed65ae8b18610a0c418be0f3b3dc6bf
https://doi.org/10.1016/j.biomaterials.2023.121994
https://doi.org/10.1016/j.biomaterials.2023.121994
Publikováno v:
Apoptosis. 25:105-119
Liver fibrosis usually progresses to liver cirrhosis and even hepatocellular carcinoma. Since activated hepatic stellate cells (aHSCs) are responsible for liver fibrosis, reducing the quantity of aHSCs was considered the essential strategy for clinic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6336f485801525ae0947dc25c0ff4284
https://doi.org/10.1007/s10495-019-01583-3
https://doi.org/10.1007/s10495-019-01583-3
Autor:
Ze Tao, Hao Yang, Qiuxia Huang, Shan Liu, Lan Li, Yanru Feng, Liqiang Hu, Hong Tan, Qiuxiao Shi, Tao Su, Shengfu Li, Yi Zhong
Publikováno v:
International Journal of Nanomedicine
Yi Zhong,1,* Tao Su,1,* Qiuxiao Shi,1 Yanru Feng,1 Ze Tao,1 Qiuxia Huang,1 Lan Li,1 Liqiang Hu,1 Shengfu Li,1 Hong Tan,2 Shan Liu,3 Hao Yang1 1Key Lab of Transplant Engineering and Immunology, MOH, West China-Washington Mitochondria and Metabolism Re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd7e3e98fb9a16b5d03adc6b4e8873d6
https://doi.org/10.2147/ijn.s219820
https://doi.org/10.2147/ijn.s219820
Autor:
Fang Xie, Ze Tao, Xiaofeng Lu, Rong Tian, Xiaoai Wu, Hao Yang, Qiuxiao Shi, Haoxing Wu, Yue Chen, Yu Tang, Huawei Cai, Nan Liu, Yuanyou Yang, Lin Li, Lihong Chen
Publikováno v:
Molecular Pharmaceutics. 16:1950-1957
Platelet-derived growth factor receptor β (PDGFRβ) is overexpressed in a variety of malignant cancers, plays a critical role in tumor angiogenesis, and has been proven as a valuable target for cancer treatment. In this pilot study, a dimeric affibo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9880f5390367579c3c32588e88d9ce8f
https://doi.org/10.1021/acs.molpharmaceut.8b01317
https://doi.org/10.1021/acs.molpharmaceut.8b01317